UBS O'Connor’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,343
Closed -$1.67M 357
2025
Q2
$1.67M Buy
53,343
+8,147
+18% +$253K 0.05% 170
2025
Q1
$1.34M Sell
45,196
-78
-0.2% -$2.34K 0.03% 160
2024
Q4
$1.34M Buy
45,274
+10,162
+29% +$321K 0.03% 207
2024
Q3
$1.09M Sell
35,112
-4,902
-12% -$178K 0.03% 266
2024
Q2
$1.36M Buy
40,014
+11,090
+38% +$566K 0.04% 253
2024
Q1
$1.88M Buy
28,924
+1,283
+5% +$88K 0.05% 183
2023
Q4
$1.89M Sell
27,641
-11,704
-30% -$608K 0.06% 179
2023
Q3
$2.04M Sell
39,345
-1,000
-2% -$59.2K 0.04% 239
2023
Q2
$2.42M Sell
40,345
-7,520
-16% -$429K 0.05% 239
2023
Q1
$2.37M Buy
+47,865
New +$2.69M 0.06% 285
2022
Q4
Sell
-34,697
Closed -$1.63M 155
2022
Q3
$1.63M Sell
34,697
-22,800
-40% -$1.09M 0.02% 675
2022
Q2
$2.15M Buy
+57,497
New +$1.87M 0.02% 629

Other funds holding IMCR